User profiles for Beth E. Snitz
Beth E. SnitzAssociate Professor of Neurology, University of Pittsburgh Verified email at upmc.edu Cited by 14913 |
Clinical versus mechanical prediction: a meta-analysis.
The process of making judgments and decisions requires a method for combining data. To
compare the accuracy of clinical and mechanical (formal, statistical) data-combination …
compare the accuracy of clinical and mechanical (formal, statistical) data-combination …
Frequent amyloid deposition without significant cognitive impairment among the elderly
Objective To characterize the prevalence of amyloid deposition in a clinically unimpaired
elderly population, as assessed by Pittsburgh Compound B (PiB) positron emission …
elderly population, as assessed by Pittsburgh Compound B (PiB) positron emission …
Cognitive deficits in unaffected first-degree relatives of schizophrenia patients: a meta-analytic review of putative endophenotypes
Cognitive deficits may index genetic liability for schizophrenia and are candidate endophenotypes
for the illness. In order to compare the degree of sensitivity among cognitive tasks to …
for the illness. In order to compare the degree of sensitivity among cognitive tasks to …
Ginkgo biloba for prevention of dementia: a randomized controlled trial
Context Ginkgo biloba is widely used for its potential effects on memory and cognition. To
date, adequately powered clinical trials testing the effect of G biloba on dementia incidence …
date, adequately powered clinical trials testing the effect of G biloba on dementia incidence …
[HTML][HTML] Astrocyte reactivity influences amyloid-β effects on tau pathology in preclinical Alzheimer's disease
An unresolved question for the understanding of Alzheimer’s disease (AD) pathophysiology
is why a significant percentage of amyloid-β (Aβ)-positive cognitively unimpaired (CU) …
is why a significant percentage of amyloid-β (Aβ)-positive cognitively unimpaired (CU) …
Ginkgo biloba for preventing cognitive decline in older adults: a randomized trial
BE Snitz, ES O'Meara, MC Carlson, AM Arnold… - Jama, 2009 - jamanetwork.com
Context The herbal product Ginkgo biloba is taken frequently with the intention of improving
cognitive health in aging. However, evidence from adequately powered clinical trials is …
cognitive health in aging. However, evidence from adequately powered clinical trials is …
Implementation of subjective cognitive decline criteria in research studies
Introduction Subjective cognitive decline (SCD) manifesting before clinical impairment
could serve as a target population for early intervention trials in Alzheimer's disease (AD). A …
could serve as a target population for early intervention trials in Alzheimer's disease (AD). A …
Subjective cognitive decline in older adults: an overview of self-report measures used across 19 international research studies
Research increasingly suggests that subjective cognitive decline (SCD) in older adults, in
the absence of objective cognitive dysfunction or depression, may be a harbinger of non-…
the absence of objective cognitive dysfunction or depression, may be a harbinger of non-…
Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees
…, MD Ikonomovic, JA Saxton, BE Snitz… - Journal of …, 2007 - Soc Neuroscience
The amyloid cascade hypothesis suggests that the aggregation and deposition of amyloid-β
protein is an initiating event in Alzheimer's disease (AD). Using amyloid imaging technology…
protein is an initiating event in Alzheimer's disease (AD). Using amyloid imaging technology…
Amyloid imaging in mild cognitive impairment subtypes
Objective We utilized the amyloid imaging ligand Pittsburgh Compound B (PiB) to determine
the presence of Alzheimer's disease (AD) pathology in different mild cognitive impairment (…
the presence of Alzheimer's disease (AD) pathology in different mild cognitive impairment (…